Rotenone Induces Apoptosis via Activation of Bad in Human Dopaminergic SH-SY5Y Cells

Chronic complex I inhibition caused by rotenone induces features of Parkinson's disease in rats, including selective nigrostriatal dopaminergic degeneration and Lewy bodies with α-synuclein-positive inclusions. To determine the mechanisms underlying rotenone-induced neuronal death, we used an in vitro model of human dopaminergic SH-SY5Y cells. In rotenone-induced cell death, rotenone induced Bad dephosphorylation without changing the amount of Bad proteins. Rotenone also increased the amount of α-synuclein in cells showing morphological changes in response to rotenone. Because Bad and α-synuclein are known to bind to 14-3-3 proteins, we examined the effects of rotenone on these complexes. Whereas a decreased Bad amount bound to 14-3-3 proteins, rotenone increased α-synuclein binding to these proteins. Beccause dephosphorylation by calcineurin activates Bad, we examined the possible involvement of Bad activation in rotenone-induced apoptosis by using the calcineurin inhibitor tacrolimus (FK506). Tacrolimus suppressed two rotenone-induced actions: Bad dephosphorylation and apoptosis. Furthermore, the inhibition of caspase-9, which functions downstream from Bad, completely suppressed rotenone-induced apoptosis. Our findings demonstrate that Bad activation plays a role in rotenone-induced apoptosis of SH-SY5Y cells.

[1]  R. Duvoisin,et al.  Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: Implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity , 1985, Neuroscience Letters.

[2]  David F. Clayton,et al.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.

[3]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[4]  B. Shastry,et al.  Parkinson disease: etiology, pathogenesis and future of gene therapy , 2001, Neuroscience Research.

[5]  C. Marsden,et al.  Mitochondrial Complex I Deficiency in Parkinson's Disease , 1990, Lancet.

[6]  E. Hirsch,et al.  Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Zamrini,et al.  Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. , 1997, The American journal of pathology.

[8]  Michel Goedert,et al.  Identification of two distinct synucleins from human brain , 1994, FEBS letters.

[9]  Y. Mizuno,et al.  Histochemical detection of apoptosis in Parkinson's disease , 1996, Journal of the Neurological Sciences.

[10]  M. Watabe,et al.  Requirement of protein kinase (Krs/MST) activation for MT-21-induced apoptosis , 1999, Oncogene.

[11]  J. Schaack,et al.  Overexpression of human α-synuclein causes dopamine neuron death in primary human mesencephalic culture , 2002, Brain Research.

[12]  A Hartley,et al.  Complex I Inhibitors Induce Dose‐Dependent Apoptosis in PC12 Cells: Relevance to Parkinson's Disease , 1994, Journal of neurochemistry.

[13]  Daniela Berg,et al.  14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta. , 2002, Brain research. Molecular brain research.

[14]  S. Metcalfe,et al.  Peptidylproline cis/trans isomerases. , 1995, Progress in biophysics and molecular biology.

[15]  J C Reed,et al.  Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. , 1999, Science.

[16]  J. Langston,et al.  Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations. , 1993, Advances in neurology.

[17]  M. Watabe,et al.  Caffeic Acid Phenethyl Ester Induces Apoptosis by Inhibition of NFκB and Activation of Fas in Human Breast Cancer MCF-7 Cells* , 2004, Journal of Biological Chemistry.

[18]  M. Watabe,et al.  Treatment of U937 cells with bufalin induces the translocation of casein kinase 2 and modulates the activity of topoisomerase II prior to the induction of apoptosis. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[19]  Anthony J. Muslin,et al.  14‐3‐3 proteins block apoptosis and differentially regulate MAPK cascades , 2000, The EMBO journal.

[20]  S. Masters,et al.  14-3-3 proteins: structure, function, and regulation. , 2000, Annual review of pharmacology and toxicology.

[21]  E. Masliah,et al.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Watabe,et al.  The Cooperative Interaction of Two Different Signaling Pathways in Response to Bufalin Induces Apoptosis in Human Leukemia U937 Cells* , 1996, The Journal of Biological Chemistry.

[23]  M. Watabe,et al.  Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells , 1998, Oncogene.

[24]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[25]  K. Chung,et al.  Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of α-synuclein , 2004 .

[26]  M. Watabe,et al.  MT-21 is a synthetic apoptosis inducer that directly induces cytochrome c release from mitochondria. , 2000, Cancer research.

[27]  J. Cooper,et al.  Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins , 1998, Brain Research.

[28]  V. Dixit,et al.  14-3-3 Proteins Associate with A20 in an Isoform-specific Manner and Function Both as Chaperone and Adapter Molecules* , 1996, The Journal of Biological Chemistry.

[29]  T. Sherer,et al.  Complex I and Parkinson's Disease , 2001, IUBMB life.

[30]  H. Fu,et al.  Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Allen,et al.  Interaction of 14-3-3 with Signaling Proteins Is Mediated by the Recognition of Phosphoserine , 1996, Cell.

[32]  D. Neill,et al.  Aggregates from mutant and wild‐type α‐synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β‐sheet and amyloid‐like filaments , 1998, FEBS letters.

[33]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[34]  M. Watabe,et al.  Caffeic acid phenethyl ester induces apoptosis by inhibition of NFkappaB and activation of Fas in human breast cancer MCF-7 cells. , 2004, The Journal of biological chemistry.

[35]  H. Makino,et al.  Initial cyclosporin A but not glucocorticoid treatment promotes recovery of striatal dopamine concentration in 6-hydroxydopamine lesioned mice , 1997, Neuroscience Letters.

[36]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[37]  Elizabeth Yang,et al.  Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.

[38]  A. Halestrap,et al.  Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. , 1994, The Biochemical journal.